CAPOZZI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.378
EU - Europa 747
AS - Asia 243
SA - Sud America 18
AF - Africa 9
OC - Oceania 3
Totale 3.398
Nazione #
US - Stati Uniti d'America 2.362
IT - Italia 353
SE - Svezia 135
IN - India 118
FI - Finlandia 68
CN - Cina 61
SG - Singapore 52
DE - Germania 34
UA - Ucraina 31
BG - Bulgaria 23
GB - Regno Unito 20
FR - Francia 19
IE - Irlanda 19
CA - Canada 14
AR - Argentina 12
BE - Belgio 11
AT - Austria 10
RO - Romania 9
TG - Togo 9
NL - Olanda 5
AU - Australia 3
BR - Brasile 3
CL - Cile 3
AZ - Azerbaigian 2
CH - Svizzera 2
KR - Corea 2
RU - Federazione Russa 2
TH - Thailandia 2
TR - Turchia 2
AL - Albania 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
RS - Serbia 1
Totale 3.398
Città #
Fairfield 353
Chandler 296
Rome 183
Ashburn 152
Woodbridge 149
Houston 140
Cambridge 128
Seattle 124
Wilmington 110
Dearborn 101
Ann Arbor 89
Princeton 65
San Paolo di Civitate 46
New York 45
Lawrence 43
Des Moines 42
Plano 42
Millbury 38
Helsinki 36
San Diego 36
Beijing 25
Sofia 23
Boston 21
Dublin 19
Andover 16
Milan 14
Federal 12
Brussels 11
Falls Church 10
Jacksonville 10
Norwalk 10
Southend 10
Toronto 10
Vienna 10
Lomé 9
Pune 9
Silvi 7
Boardman 6
Fremont 6
Los Angeles 6
Singapore 6
Bühl 5
Cernobbio 5
Nanjing 5
Arezzo 4
Hefei 4
London 4
Phoenix 4
Ariccia 3
Buffalo 3
Caserta 3
Fasano 3
Nanchang 3
Ottawa 3
Redwood City 3
San Mateo 3
Shenyang 3
Spresiano 3
Bangkok 2
Campobasso 2
Chengdu 2
Dallas 2
Florence 2
Grugliasco 2
Guangzhou 2
Gwangmyeong-si 2
Hangzhou 2
Hyderabad 2
Indiana 2
Istanbul 2
Jinan 2
Kunming 2
La Jolla 2
Modena 2
Naples 2
Perth 2
Redmond 2
Rieti 2
Saint-Fons 2
Shanghai 2
Zhengzhou 2
Acton 1
Alessandria 1
Amsterdam 1
Athens 1
Bad Bellingen 1
Baki 1
Baku 1
Beograd 1
Berlin 1
Bern 1
Bishkek 1
Bonndorf 1
Cachoeiro de Itapemirim 1
Changsha 1
Chaoyang 1
Durham 1
Fuzhou 1
Grafing 1
Groningen 1
Totale 2.594
Nome #
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs 119
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome 103
Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies 98
Antibodies to age-β2 glycoprotein I in patients with antiphospholipid antibody syndrome. 90
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus. 88
A monocentric cohort of obstetric seronegative anti-phospholipid syndrome 85
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome 80
Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies 80
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies" 79
Autophagy induces protein carbamylation in fibroblast-like synoviocytes from patients with rheumatoid arthritis 78
Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts 78
Biochemistry and neurobiology of prosaposin: A potential therapeutic neuro-effector 77
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 75
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis 75
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome 74
TLC immunostaining for detection of "antiphospholipid" antibodies 73
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome 70
Modulatory Effect of Gliadin Peptide 10-mer on Epithelial Intestinal CACO-2 Cell Inflammatory Response 70
Neuroglobin overexpression plays a pivotal role in neuroprotection through mitochondrial raft-like microdomains in neuroblastoma SK-N-BE2 cells 69
Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System 69
Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease 69
Oxidized Human Beta2-Glycoprotein I: Its Impact on Innate Immune Cells 68
Association of anti-C1 inhibitor and anti-protein S antibodies in a patient with primary anti- phospholipid syndrome 68
A new 4-phenyl-1,8-naphthyridine derivative affects carcinoma cell proliferation by impairing cell cycle progression and inducing apoptosis. 68
Advanced glycation end products of human beta(2) glycoprotein I modulate the maturation and function of DCs 64
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome 64
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. 64
A multimolecular signaling complex including PrPC and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator 64
LRP6 mediated signal transduction pathway triggered by tissue plasminogen activator acts through lipid rafts in neuroblastoma cells 63
Detection of antiphospholipid antibodies by automated chemiluminescence assay 61
The mosaic of "seronegative" antiphospholipid syndrome. 60
Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination 57
Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs 55
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests 54
Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease 54
Screening of endothelial expression libraries for the identification of novel autoantigens involved in distinct autoimmune diseases characterized by endothelial dysfunction 53
Anti-vimentin/cardiolipin IgA in the antiphospholipid syndrome: a new tool for “seronegative” diagnosis 51
Role of erlins in the control of cell fate through lipid rafts 48
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative Antiphospholipid Syndrome 47
Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. 47
null 45
Carbamylation of β2-GPI generates new autoantigens for antiphospholipid syndrome. a new tool for diagnosis of "seronegative" patients 44
Molecular mechanisms of “antiphospholipid antibodies” and their paradoxical role in the pathogenesis of “seronegative APS” 43
The role of cardiolipin as a scaffold mitochondrial phospholipid in autophagosome formation: In vitro evidence 42
Effect of Heparanase inhibitor on Tissue Factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies 42
Anti-β2-GPI antibodies induce monocyte release of TNFα and tissue factor by signal transduction pathways involving lipid rafts. 41
Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies. Reply to comment from Mackman et al 41
T CELL REACTIVITY TO β2 GLYCOPROTEIN I IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-PHOSPHOLIPID SYNDROME: CORRELATION WITH SUBCLINICAL ATHEROSCLEROSIS. 40
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells 40
Anti-β2-GPI antibodies induce endothelial cell expression of tissue factor by LRP6 signal transduction pathway involving lipid rafts 39
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: Focus on β2GPI-Specific T cell response 38
Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome 37
“METHOD AND KIT FOR IN VITRO DIAGNOSIS OF ANTI-PHOSPHOLIPID SYNDROME” 33
Effect on microtubules and antitumor activity by newly synthesized 1,8-naphtyridine derivatives 31
Post-translational modifications of proteins in antiphospholipid antibody syndrome 31
Aterosclerosi subclinica in pazienti affetti da lupus eritematoso sistemico e sindrome da anticorpi antifosfolipidi 28
Screening of microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzeimer’s disease. 27
Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation 22
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis 21
null 20
Overexpression of neuroglobin promotes energy metabolism and autophagy induction in human neuroblastoma SH-SY5Y cells 20
Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome. Molecular Mechanisms and Signaling through Lipid Rafts 16
Anti-proliferative properties and proapoptotic function of new CB2 selective cannabinoid receptor agonist in jurkat leukemia cells 14
Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma Cells 12
Oxidative stress as a regulatory checkpoint in the production of Antiphospholipid Autoantibodies: the protective role of NRF2 Pathway 9
Role of lipid rafts on LRP8 signaling triggered by anti-β2-GPI antibodies in endothelial cells 8
The Role of Autophagy as a Trigger of Post-Translational Modifications of Proteins and Extracellular Vesicles in the Pathogenesis of Rheumatoid Arthritis 3
UN SOTTOGRUPPO DI ANTICORPI ANTI-BETA2 GLICOPROTEINA I CROSS-REAGISCE CON IL TOLL-LIKE RECEPTOR 4 INDUCENDO UN FENOTIPO PROINFIAMMATORIO NELLE CELLULE ENDOTELIALI E NEI MONOCITI 1
Totale 3.597
Categoria #
all - tutte 11.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 86
selected - selezionate 0
volume - volumi 0
Totale 11.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019210 0 0 0 0 0 0 0 0 0 0 107 103
2019/2020685 87 18 7 21 81 128 97 71 68 52 35 20
2020/2021372 32 21 13 16 18 17 17 27 50 98 30 33
2021/2022758 27 33 60 44 87 33 21 69 57 65 144 118
2022/2023861 132 185 56 138 67 124 4 50 63 3 20 19
2023/2024458 35 60 35 23 62 78 32 51 16 66 0 0
Totale 3.597